Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine
FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory…
Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine
FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a common complication of the allogeneic stem cell transplants that are a standard treatment for certain blood cancers. The post Orca Bio Cell Therapy Gets Landmark FDA…
How did Washington State’s PDAB select drugs?
Many policymakers are looking for ways to reduce drug spending. Federal policymakers are not the only ones looking at the issue. In recent years, state Prescription Drug Affordability Boards (PDABs) have formed to reduce drug prices. A paper by Barthold et al. (2026) describes the what PDABs are: As of April 2025, 12 states had…
Evernorth Invests $100M for AI Specialty Pharmacy Program
Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care. The post Evernorth Invests $100M for AI Specialty Pharmacy Program appeared first on MedCity News.
Medical Frailty and Medicaid Work Requirements: Challenges for People with HIV
This analysis examines Medicaid work requirements and the implementation of medical frailty exclusions for people with HIV in light of CMS’s implementing regulation.
How Has Projected Medicaid Spending and Enrollment Changed Since Passage of the 2025 Reconciliation Law?
CBO’s latest projections of Medicaid spending and enrollment from February 2026 show how enrollment and spending are expected to change over the next decade, accounting for the historic policy changes and their expected reductions in future federal Medicaid spending, as well as other economic and technical changes. This policy watch compares CBO’s February 2026 projections…
Medicare Will Spend More Than $13 Billion on the Medicare Advantage Quality Bonus Program in 2026
The Medicare program will spend at least $13 billion on the Medicare Advantage quality bonus program in 2026, as 68% of Medicare Advantage enrollees are in a plan that qualifies for higher payments under the program.
Decoding Medicare Advantage Coding Intensity
In recent years, federal payments to Medicare Advantage plans, and how they are adjusted for enrollee health status, have come under increased scrutiny. This brief answers key questions about coding intensity, recent steps taken by CMS to address the impact of coding on payment, the effects on Medicare beneficiaries, and other proposals to improve Medicare…
MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative
In this episode, we’re joined by Dr. Cathleen Brown, medical director of menopause company Winona. We discuss the company’s new Winona Research Initiative, which seeks to fund and support menopause and women’s health research. The post MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative appeared first on MedCity News.
Your Healthcare AI Strategy Is Probably an Architecture Problem
These three patterns keep showing up, and each is much cheaper to prevent than to fix later. The post Your Healthcare AI Strategy Is Probably an Architecture Problem appeared first on MedCity News.
Healthcare Retention Depends On Better Pathways, Not Just Better Pay
When workers feel stuck in place, with limited opportunities to advance or deepen their skills, disengagement tends to follow. In allied health roles, where burnout is already high and many touch the patient experience, it is a risk healthcare employers cannot afford to ignore. The post Healthcare Retention Depends On Better Pathways, Not Just Better…
